Clinical trials have gone global: Is this a good thing?

PLoS Medicine

Volumn 9, Issue 6, 2012, Pages 6-

  Lang, Trudie ^a   Siribaddana, Sisira ^b,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b RAJARATA UNIVERSITY OF SRI LANKA   (Sri Lanka)

^c Institute of Research and Development   (Sri Lanka)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL STUDY; COMMUNITY MEDICINE; DISEASE ACTIVITY; DRUG EFFICACY; DRUG RESEARCH; DRUG SAFETY; GOOD CLINICAL PRACTICE; GOVERNMENT REGULATION; HEALTH CARE COST; HUMAN; PROFESSIONAL STANDARD; CLINICAL TRIAL (TOPIC); ETHICS; INTERNATIONAL COOPERATION; PRACTICE GUIDELINE; REVIEW;

CLINICAL TRIALS AS TOPIC; HUMANS; INTERNATIONALITY; PRACTICE GUIDELINES AS TOPIC;

EID: 84864681570     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001228     Document Type: Article

References (16)

1. Laine C, Horton R, DeAngelis CD, Drazen JM, Frizelle FA, et al. (2009) Clinical trial registration - looking back and moving ahead. N Engl J Med 356: 2734-2736.
2. Morgan S, Grootendorst P, Lexchin J, Cunningham C, Greyson D, (2011) The cost of drug development: a systematic review. Health Policy 100: 4-17.
3. Yusuf S, Bosch J, Devereaux P, (2008) Sensible guidelines for the conduct of large randomized trials. Clin Trials 5: 38-39.
4. Lang T, Cheah PY, White NJ, (2011) Clinical research: time for sensible global guidelines. Lancet 377: 1553-1555.
5. Glickman SW, McHutchison JG, Peterson ED, Cairns CB, Harrington RA, et al. (2009) Ethical and scientific implications of the globalization of clinical research. N Engl J Med 360: 816-823.
6. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (1996) Guideline for good clinical practice E6(R1) Geneva International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use.
7. Grant AM, Altman DG, Babiker AB, Campbell MK, Clemens FJ, et al. (2005) Issues in data monitoring and interim analysis of trials. Health Technol Assess 9: 1-238 iii-iv.
8. Grignolo A, (2011) The Clinical Trials Transformation Initiative (CTTI). Annali dell'Istituto superiore di sanita 47: 14-18.
9. Ateudjieu J, Williams J, Hirtle M, Baume C, Ikingura J, et al. (2010) Training needs assessment in research ethics evaluation among research ethics committee members in three African countries: Cameroon, Mali and Tanzania. Dev World Bioeth 10: 88-98.
10. de Silva HA, Pathmeswaran A, Ranasinha CD, Jayamanne S, Samarakoon SB, et al. (2011) Low-dose adrenaline, promethazine, and hydrocortisone in the prevention of acute adverse reactions to antivenom following snakebite: a randomised, double-blind, placebo-controlled trial. PLoS Med 8: e1000435 doi:10.1371/journal.pmed.1000435.
11. Nundy S, Gulhati CM, (2005) A new colonialism?-Conducting clinical trials in India. N Engl J Med 352: 1633-1636.
12. Lang TA, Gould J, von Seidlein L, Lusingu JP, Mshamu S, et al. (2012) Approaching the community about screening children for a multicentre malaria vaccine trial. International Health 4: 47-54.
13. Lang TA, White NJ, Tran HT, Farrar JJ, Day NP, et al. (2010) Clinical research in resource-limited settings: enhancing research capacity and working together to make trials less complicated. PLoS Negl Trop Dis 4: e619 doi:10.1371/journal.pntd.0000619.
14. Brosteanu O, Houben P, Ihrig K, Ohmann C, Paulus U, et al. (2009) Risk analysis and risk adapted on-site monitoring in noncommercial clinical trials. Clin Trials 6: 585-596.
15. de Silva HJFM, Gunatilake SB, Kularatne SAM, Sellahewa KH, (2002) Anti-venom for snakebite in Sri Lanka. Ceylon Medical Journal 47: 43-45.
16. Juurlink DN, Sivilotti ML, (2003) Multidose activated charcoal for yellow oleander poisoning. Lancet 362: 581; author reply 581.